SEC CIK 1585223
Duchemin Jeffrey
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| HBIOview stock → | 464,528 | 2019-07-07 |
Position History — HBIO
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — HBIO
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2019-07-07 | Disposition to issuer | 285,473 | $0.00 | 464,528 |
| 2019-06-28 | J | 3,334 | $1.70 | 750,001 |
| 2019-05-24 | Tax withholding | 1,111 | $2.31 | 746,667 |
| 2019-04-12 | Open-market sale | 400 | $4.65 | 830,888 |
| 2019-04-11 | Open-market sale | 12,425 | $4.51 | 831,288 |
| 2019-04-10 | Open-market sale | 6,332 | $4.50 | 843,713 |
| 2019-03-07 | Grant / award (derivative) | 271,139 | $0.00 | 271,139 |
| 2019-03-07 | Grant / award | 113,034 | $0.00 | 793,528 |
| 2019-03-07 | Grant / award | 56,517 | $0.00 | 850,045 |
| 2019-01-01 | Tax withholding | 61,755 | $3.18 | 680,494 |
| 2018-08-09 | Option exercise (derivative) | 44,500 | $0.00 | 350,000 |
| 2018-08-09 | Open-market sale | 44,500 | $6.41 | 790,742 |
| 2018-08-09 | Option exercise | 44,500 | $4.31 | 835,242 |
| 2018-08-08 | Option exercise (derivative) | 5,500 | $0.00 | 394,500 |
| 2018-08-08 | Option exercise | 5,500 | $4.31 | 796,242 |
| 2018-08-08 | Open-market sale | 5,500 | $6.35 | 790,742 |
| 2018-08-07 | Option exercise (derivative) | 100,000 | $0.00 | 400,000 |
| 2018-08-07 | Option exercise | 100,000 | $4.31 | 890,742 |
| 2018-08-07 | Open-market sale | 100,000 | $6.07 | 790,742 |
| 2018-08-03 | Tax withholding | 12,619 | $5.70 | 742,249 |
| 2018-07-11 | Open-market sale | 14,205 | $5.22 | 790,742 |
| 2018-07-10 | Open-market sale | 11,600 | $5.38 | 804,947 |
| 2018-07-09 | Open-market sale | 14,195 | $5.41 | 816,547 |
| 2018-05-24 | Grant / award | 94,444 | $0.00 | 830,742 |
| 2018-05-24 | Grant / award | 94,444 | $0.00 | 736,298 |
| 2018-03-09 | Open-market sale | 7,800 | $4.60 | 641,854 |
| 2018-03-08 | Open-market sale | 79,222 | $4.52 | 649,654 |
| 2018-01-01 | Tax withholding | 60,108 | $3.30 | 728,876 |
| 2017-06-12 | Open-market buy | 22,000 | $2.76 | 810,984 |
| 2017-06-12 | Open-market sale | 22,000 | $2.66 | 788,984 |
| 2017-05-25 | Grant / award | 357,609 | $0.00 | 788,984 |
| 2017-01-01 | Tax withholding | 31,248 | $3.05 | 431,375 |
| 2016-11-03 | Open-market buy | 15,000 | $2.42 | 462,623 |
| 2016-05-06 | Grant / award | 291,667 | $0.00 | 447,623 |
| 2016-01-01 | Tax withholding | 6,474 | $3.47 | 155,956 |
| 2015-12-31 | J | 2,220 | $2.95 | 162,430 |
| 2015-12-10 | Open-market buy | 10,000 | $3.37 | 160,210 |
| 2015-09-02 | Open-market buy | 2,000 | $4.41 | 150,210 |
| 2015-08-03 | Grant / award | 71,748 | $0.00 | 148,210 |
| 2015-06-30 | J | 2,276 | $4.67 | 76,462 |
| 2015-06-04 | Grant / award (derivative) | 130,000 | $0.00 | 130,000 |
| 2015-06-04 | Grant / award | 68,900 | $0.00 | 74,186 |
| 2014-12-31 | J | 3,366 | $4.00 | 6,374 |
| 2014-12-31 | J | 2,278 | $4.00 | 5,286 |
| 2014-06-30 | J | 3,008 | $3.87 | 3,008 |
| 2014-05-30 | Grant / award (derivative) | 300,000 | $0.00 | 300,000 |
| 2013-11-18 | Grant / award (derivative) | 500,000 | $0.00 | 500,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.